A weakened inflammatory response in GSDMD−deficient NSCLC cells may interrupt the negative feedback regulation that activates the phosphoinositide-3-kinase (PI3K)/Akt pathway. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.